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Introduction: COVID-19 has had a huge impact on society and healthcare and it
has been suggested that people with periodontal disease are at risk of having worse
outcomes from the disease. The aim of this study was to quantify the impact of
periodontal disease on hospital admission and mortality during the COVID-19 pandemic.
Materials and Methods: The study extracted UK Biobank participants who had taken
a COVID-19 test between March and June 2020 (n = 13,253), of which 1,616 were
COVID-19 positive (12%) and 11,637 were COVID-19 negative (88%). Self-reported oral
health indicators of painful or bleeding gums and loose teeth were used as surrogates for
periodontal disease, participants who did not report any of the aforementioned indicators
were used as controls. Multivariable logistic regressions were used to obtain crude and
adjusted odds ratios of COVID-19 infection, subsequent hospital admission andmortality
adjusted for demographics, BMI, biomarkers, lifestyle and co-morbidities.
Results: Painful gums, bleeding gums and loose teeth were reported in 2.7, 11.2 and
3.3% of participants with COVID-19 infection, respectively. Risk of COVID-19 infection
in participants with painful or bleeding gums and loose teeth compared to controls
was not increased (odds ratio [OR]: 1.10, 95% CI: 0.72–1.69; OR: 1.15, 95% CI:
0.84–1.59). COVID-19 positive participants with painful or bleeding gums had a higher
risk of mortality (OR: 1.71, 95% CI: 1.05–2.72) but not hospital admission (OR: 0.90,
95% CI: 0.59–1.37). Participants with loose teeth did not show higher risk of hospital
admission or mortality compared to the control group (OR = 1.55, 95% CI: 0.87–2.77;
OR: 1.85; 95% CI: 0.92–2.72).
Conclusion: There was insufficient evidence to link periodontal disease with an
increased risk of COVID-19 infection. However, amongst the COVID-19 positive, there
was significantly higher mortality for participants with periodontal disease. Utilization of
linked dental and hospital patient records would improve the understanding of the impact
of periodontal disease on COVID-19 related outcomes.
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INTRODUCTION
The COVID-19 pandemic has resulted in a huge burden on
society and healthcare. Studies have shown that sex, older age and
co-morbidities including diabetes, hypertension, cardiovascular
disease and cancer may increase risk of COVID-19 associated
deaths (1, 2). There are also suggestions that COVID-19 related
deaths may be associated with deprivation and ethnicity (3). As
yet no study has examined the impact of periodontal disease on
COVID-19 infection and associated outcomes.
Over a lifetime, ∼90% of adults will experience oral disease.
Periodontal disease is a main cause of tooth loss in adults and
the sixth most prevalent disease globally (4), affecting between 10
and 50% of adults (5, 6). Existing evidence suggests that people
with periodontitis may have an increased risk in developing
subsequent systemic diseases including cardiovascular disease,
hypertension, respiratory disease, diabetes and cancer (7–12).
It has been suggested that COVID-19 could be linked to
periodontal disease given their shared risk factors, which include
obesity, age and hypertension (13, 14). Additionally, there
is growing evidence of bacterial co-infection in COVID-19
hospitalizations (15), while ventilator associated pneumonia
is also a reported complication of patients hospitalized with
COVID-19 (16). Oral dysbiosis as a result of increased dental
plaque in periodontitis may provide an environment for
oral carriage of respiratory pathogens and cause COVID-19
complications. As yet there is insufficient evidence to provide
robust conclusions on how periodontal disease may be associated
to COVID-19 infection and outcomes.
During the COVID-19 pandemic UK Biobank has provided
live-feed information of its participants on COVID-19 testing,
subsequent hospital admission and mortality. The UK Biobank
dataset provides an extensive resource to aid in understanding
the impact of various factors including periodontal disease
during the pandemic. The aim of this study was to quantify the
impact of periodontal disease on COVID-19 infection and related
outcomes utilizing the UK Biobank data.
MATERIALS AND METHODS
Database
Data from the UK Biobank cohort was used in this analysis.
UK Biobank is a national, longitudinal cohort study of over
500,000 participants. The dataset includes information from UK
Biobank assessment centers; self-reported responses via online
questionnaires, linked HES data including ICD-10 diagnoses
and hospital admissions provided by NHS Digital, and death
records extracted from the death register. Since 16th March 2020
COVID-19 test results provided by Public Health England have
been linked to UK Biobank core data as a live-feed for the
purposes of COVID-19 related research during the pandemic.
The COVID-19 test result data reflects the change in national
testing capacity, which has moved from mostly inpatient to
more community testing. The data is accessible by researchers
with an approved UK Biobank application (reference no: 54633)
for a prior study and may carry out additional COVID-19
related research without further approval according to UK
Biobank guidelines.
Study recruitment was between 2006 and 2010. Linked follow-
up information from HES and death records were available
until May and June 2020, respectively. COVID-19 test results
were available until the date of data extraction (August 2020).
All participant information was fully anonymised prior to data
acquisition. HES data, death records and COVID-19 test results
were linked to the core UK Biobank dataset by a unique study
ID therefore we do not anticipate any missing outcome data.
Participants are free to remove themselves from the UK Biobank
study cohort at any point (17).
Study Sample
For this study we included participants who were tested for
COVID-19 (n = 13,502) with their results linked to the core
UK Biobank dataset. The final dataset included information on
participant demographics, biomarkers, co-morbidities, COVID-
19 test results, hospital admissions and mortality.
Study Outcomes
Hospital admission and mortality following positive COVID-19
test result.
Exposures
The self-reported oral health indicators of bleeding gums, painful
gums and loose teeth were utilized as surrogates for periodontal
disease as they have demonstrated their validity in the absence
of a clinical diagnosis (18). Painful and bleeding gums were
associated with mild to moderate periodontal disease, while
loose teeth indicated severe periodontal disease. Periodontal
disease status was determined by the presence of any of the
aforementioned indicators, while no mention of the indicators
identified the control group, comprising participants with no
self-reported history of periodontal disease.
Covariates
Information on participant demographics (age, sex, ethnicity,
household income) and BMI was collated during attendance
to UK Biobank assessment centers. Periodontal disease status
was also determined from self-reported responses taken from
UK Biobank assessment centers. Age at COVID-19 test was
derived from age at assessment center attendance and date of
test. Information on biomarkers such as blood pressure (systolic
and diastolic) and resting heart rate was also acquired from
attending UK Biobank assessment centers. Where there were
multiple entries for biomarkers the most recent report was
extracted. History of smoking was derived according to self-
reported current or ex-smoking status. The following conditions
were also considered as covariates: cancer, hypertension, angina,
cardiac arrest, diabetes, myocardial infarction (MI), stroke,
peripheral artery disease (PAD), heart failure, atrial fibrillation
and respiratory conditions. Validated ICD-10 code lists within
the Cardiovascular Research Using Linked Bespoke Studies and
Electronic Health Records (CALIBER) resource were used to
classify the aforementioned conditions (19), and the presence
of the appropriate ICD-10 code in a participants health records
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denoted history of the disease. The code list meanings were
also adapted to identify relevant self-reported conditions that
were not coded with ICD-10 classification. Participants were
considered to have disease history if relevant ICD-10 codes were
found in their health records, or if the condition was self-reported
at the assessment center. No participants had history of heart
failure therefore it was excluded from further analysis. A history
of hypertension was determined if ICD-10 code was present in
health record data, or if the blood pressure reading from the
assessment center exceeded 140/90 mmHg.
Data Analysis
Descriptive statistics for baseline characteristics were presented
using frequency (percentage) for categorical data and mean
[standard deviation (SD)] or median [interquartile range (IQR)]
for continuous variables depending on their distribution.
Among participants who had COVID 19 test results available,
the risk of COVID-19 infection was investigated for those
with periodontal disease (self-reported painful gums,
bleeding gums or loose teeth) using logistic regression, and
further adjusted for covariates including demographics, BMI,
TABLE 1 | Summary table of UK Biobank participants stratified by oral health indicator and COVID-19 test result.
No self-reported history
of periodontal disease
Painful gums Bleeding gums Loose teeth
COVID-19 test result COVID-19 test result COVID-19 test result COVID-19 test result
Overall – + – + – + – +
n 13,253 9,815 1,338 321 44 1,148 181 353 53
Age at test, mean (SD) 68.55 (8.38) 69.10 (8.20) 67.15 (9.19) 67.88 (8.71) 69.27 (9.20) 66.10 (8.22) 63.24 (8.50) 69.82 (7.27) 68.13 (8.28)
Sex, female (%) 6,802 (51.3) 5,026 (51.2) 627 (46.9) 174 (54.2) 18 (40.9) 677 (59.0) 98 (54.1) 150 (42.5) 32 (60.4)





3,349 (28.3) 411 (4.7) 34 (2.9) 114 (43.3) 11 (29.7) 263 (27.0) 40 (26.0) 126 (43.4) 21 (51.2)
18,000–30,999 2,836 (24.0) 2,108 (24.1) 279 (23.5) 59 (22.4) 13 (35.1) 256 (26.3) 43 (27.9) 73 (25.2) 5 (12.2)
31,000–51,999 2,578 (21.8) 1,925 (22.0) 258 (21.8) 47 (17.9) 6 (16.2) 235 (24.2) 42 (27.3) 54 (18.6) 11 (26.8)
52,000–100,000 1,871 (15.8) 1,424 (16.3) 180 (15.2) 36 (13.7) 5 (13.5) 171 (17.6) 21 (13.6) 30 (0.3) 4 (9.8)
>100,000 517 (4.4) 481 (5.5) 73 (6.2) 7 (2.7) 2 (5.4) 48 (4.9) 8 (5.2) 7 (2.4) NA








82.27 (10.79) 82.16 (10.74) 82.73 (11.16) 81.42 (9.86) 83.49 (10.76) 82.55 (10.92) 82.65 (10.99) 83.18 (10.77) 81.08 (11.95)
Resting heart
rate/BPM, mean (SD)
63.85 (9.87) 64.12 (10.29) 57.67 (5.20) 58.00 (NA) NA 67.14 (8.91) 65.00 (NA) 74.50 (7.78) NA
History of smoking (%) 6,731 (51.0) 4,937 (50.5) 677 (51.0) 186 (58.7) 25 (56.8) 538 (47.0) 82 (45.6) 256 (73.1) 30 (56.6)
Cancer (%) 2,334 (17.6) 1,813 (18.50) 179 (13.4) 53 (16.5) 2 (4.5) 190 (16.6) 23 (12.7) 66 (18.7) 8 (15.1)
Hypertension (%) 7,781 (58.7) 5,776 (58.8) 793 (59.3) 197 (61.4) 31 (70.5) 636 (55.4) 90 (49.7) 229 (64.9) 29 (54.7)
Angina (%) 1,711 (12.9) 1,251 (12.7) 159 (11.9) 64 (19.9) 13 (29.5) 135 (11.8) 20 (11.0) 61 (17.3) 8 (15.1)
Cardiac arrest (%) 204 (1.5) 160 (1.6) 20 (1.5) 6 (1.9) NA 11 (1.0) 1 (0.6) 5 (1.4) 1 (1.9)
Diabetes (%) 551 (4.2) 376 (3.8) 62 (4.6) 26 (8.1) 3 (6.8) 36 (3.1) 10 (5.5) 31 (8.8) 7 (13.2)
Myocardial infarction
(%)
1,133 (8.5) 830 (8.5) 114 (8.5) 56 (17.4) 5 (11.4) 74 (6.4) 14 (7.7) 37 (10.5) 3 (5.7)
Stroke (%) 769 (5.8) 547 (5.6) 92 (6.9) 35 (10.9) 5 (11.4) 55 (4.8) 8 (4.4) 22 (6.2) 5 (9.4)
Peripheral artery
disease (%)
963 (7.3) 695 (7.1) 110 (8.2) 36 (11.2) 2 (4.5) 67 (5.8) 12 (6.6) 36 (10.2) 5 (9.4)
Atrial fibrillation (%) 1,100 (8.3) 826 (8.4) 116 (8.7) 34 (10.6) 5 (11.4) 74 (6.4) 16 (8.8) 30 (8.5) 1 (1.9)
Respiratory disease (%) 3,056 (23.1) 2,213 (22.5) 335 (25.0) 88 (27.4) 9 (20.5) 255 (22.2) 49 (27.1) 96 (27.2) 11 (20.8)
Hospital admission 4,083 (30.2%) 2,723 (27.7) 665 (49.7) 89 (27.7) 18. (40.9) 297 (25.9) 81 (44.8) 101 (28.6) 26 (49.1)
Mortality 644 (4.8%) 292 (3.0) 247 (18.5) 12 (3.7) 7 (15.9) 25 (2.2) 21 (11.6) 11 (3.1) 16 (30.2)
BMI, body mass index; n, number of participants; SD, standard deviation; NA, not applicable as not enough data; –, negative COVID-19 test result; +, positive COVID-19 test result.
Means and percentages are calculated for variables excluding missing data. There was missing data in the following variables: oral health (1.88%), ethnicity (0.3%), household income
(15.9%), BMI (3.0%), systolic and diastolic blood pressure readings (3.4%), heart rate (99.4%), history of smoking (0.4%).
Frontiers in Medicine | www.frontiersin.org 3 November 2020 | Volume 7 | Article 604980
Larvin et al. Oral Health and COVID-19
biomarkers, lifestyles and comorbidities. Among participants
with a positive COVID-19 test result, the risks of hospital
admission and mortality were investigated for those with
periodontal disease using logistic regression and further
adjusted for the relevant covariates mentioned above. Crude
and adjusted odds ratios (OR) with 95% confidence interval
were reported.
Multiple imputations were used for missing data, and Rubin’s
rule was used to combine the coefficients (20). To assess the
impact of missing data, sensitivity analyses were performed using
only the complete cases. Data processing and analyses were
performed using R version 4.0.0 (21). Statistical significance level
was set as 0.05.
RESULTS
Of the 13,253 participants involved in the final analysis cohort,
there were 365 (2.4%) participants with painful gums, 1,329
(8.7%) with bleeding gums, 406 (2.7%) with loose teeth and
11,153 (84.1%) with no self-reported history of periodontal
disease. Overall there were 1,616 (10.5%) confirmed COVID-19
cases and 11,637 negative test results in the study sample.
The mean age of all participants was 68.55± 8.38 years. There
were 51.3% females in the final cohort. 92.9% of participants
were of white ethnicity. On average participants were considered
overweight with a mean BMI of 28.24 ± 5.18.Mean BMI was
higher in COVID-19 positive participants when compared to
negative participants across all periodontal disease indicator
groups. 58.7% of all participants had a history of hypertension
and 23.1% had respiratory disease (Table 1).
COVID-19 infection risk was not higher in participants with
painful/bleeding gums or loose teeth compared to controls (OR
= 1.10, 95% CI = 0.72–1.69; OR = 1.15, 95% CI = 0.84–1.59)
(Table 2).
Though participants with painful/bleeding gums did not have
a higher risk of hospital admission (OR = 0.90, 95% CI = 0.59–
1.37), their mortality was almost doubled (OR = 1.71, 95% CI
= 1.05–2.72) compared to the control group. Participants with
loose teeth did not have significantly increased risk of hospital
TABLE 2 | Association between oral health indicators and risk of COVID-19
infection.




Crude OR (95% CI) 1 (ref) 1.07 (0.70-1.63) 0.99 (0.73-1.38)
Adjusted* OR (95% CI) 1 (ref) 1.10 (0.72-1.69) 1.15 (0.84-1.59)
CI, confidence interval; OR, odds ratio; ref, reference value.
*Adjusted by age at test, sex, ethnicity, average total household income, BMI, systolic
and diastolic blood pressure, history of smoking, history of previous conditions including:
cancer, hypertension, angina, cardiac arrest, diabetes, myocardial infarction, stroke,
peripheral artery disease, atrial fibrillation, and respiratory disease.
admission or mortality (OR = 1.55, 95% CI = 0.87–2.77; OR =
1.85; 95% CI= 0.92–2.72) (Table 3).
Sensitivity analysis on complete cases showed similar effects
of periodontal disease on COVID-19 infection risk, hospital
admission and mortality rate, but the effects were not significant
due to a smaller sample size.
DISCUSSION
Our study did not find a difference in the risk of COVID-19
infection between participants with periodontal disease and those
with no self-reported history of periodontal disease. However,
logistic regression showed that participants with painful or
bleeding gums were at much higher risk of mortality following
COVID-19 infection after adjusting for covariates, though
hospital admission risk was not higher in these participants.
Loose teeth did not affect COVID-19 infection risk, or hospital
admission and mortality following COVID-19 infection.
In this study, risk of mortality was significantly increased in
participants with painful or bleeding gums following COVID-
19 infection. A recent retrospective study of COVID-19 patients
found dominant bacterial, viral and fungi co-infections in ∼94%
of cases (22). These pathogens have also been identified in the
oral biofilms associated with periodontal disease (23). Our results
suggest oral bacterial load in people with periodontal disease may
influence prognosis following COVID-19 infection, and supports
the suggestion that the oral microbiome could be associated
with severe COVID-19 complications (13). Conversely, risk of
hospital admission following COVID-19 infection in participants
with painful or bleeding gums did not significantly increase. This
could be due to a reduction in the number of people attending
hospital for acute disease during the social containment mandate
(“lockdown”) period of the pandemic (24). People with severe
COVID-19 may have chosen to avoid hospital which may have
impacted the risk estimates for this outcome. The follow up time
for mortality outcomes from the UK Biobank cohort was longer
than for theHES data available in determining hospital admission
(June 2020 and May 2020, respectively). This may also influence
the accuracy of estimates for risk of hospital admission.
Risk of hospital admission and mortality was not higher in
participants with self-reported loose teeth, due to smaller sample
size in this subgroup. Loose teeth is an indicator of severe
periodontal disease (25). Participants with this response in the
UK Biobank cohort could have since undergone periodontal
treatment, had the affected teeth extracted, or in severe cases,
the affected teeth may have self-exfoliated. This could result in a
change in participant oral health status between the time of self-
report and the COVID-19 infection as most of the self-reported
information was collected at baseline. A study of a larger sample
size with up-to-date dental measures is required to understand
this phenomenon.
The results of this study have clinical implications for the
management of COVID-19 infections in the general population,
and in hospitalized patients. In England, routine dental services
were suspended in March 2020 (26) and, at the time of writing,
two-thirds of dental practices were operating at or below 25% of
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TABLE 3 | Association between oral health indicators and hospital admission and mortality for participants with COVID-19 infection.
Crude OR (95% CI) for oral health status Adjusted* OR (95% CI) for oral health status
Control Painful or bleeding gums Loose teeth Control Painful or bleeding gums Loose teeth
Hospital admission 1 (ref) 0.99 (0.13–3.02) 0.88 (0.16–10.04) 1 (ref) 0.91 (0.12–2.94) 0.90 (0.16–10.63)
Mortality 1 (ref) 1.60 (1.03–2.42) 1.34 (0.71–2.76) 1 (ref) 1.71 (1.05–2.72) 1.85 (0.92–2.72)
CI, confidence interval; OR, odds ratio; ref, reference value.
*Adjusted by age at test, sex, ethnicity, average total household income, BMI, systolic and diastolic blood pressure, history of smoking, history of previous conditions including: cancer,
hypertension, angina, cardiac arrest, diabetes, myocardial infarction, stroke, peripheral artery disease, atrial fibrillation, and respiratory disease.
their pre-COVID-19 activity levels (27). Dental practices are also
having difficulties sourcing Personal Protective Equipment (PPE)
(28). In the absence of routine dental care, remote consultations
are an opportunity to emphasize self-care methods such as
thorough brushing and interdental cleaning, both to prevent
oral disease and to reduce the risk of COVID-19 mortality. UK
government strategy has focused on tackling obesity to reduce the
risk of serious illness or death from COVID-19 (29). Our results
show that periodontal disease may be another preventable risk
factor that the government could target to improve population
outcomes before and after COVID-19 infection. The oral health
of patients who have been hospitalized with COVID-19 should
not be neglected. There is a wealth of evidence establishing an
association between good hospital mouth-care and a reduced
risk of pneumonia and acute viral respiratory infections (13).
Furthermore, simple measures such as chlorhexidine mouth
rinses have been shown to reduce the risk of ventilator associated
pneumonia in critically ill patients from 24 to 18% (30).
Improving the mouth care provided to COVID-19 patients
in hospital could be a straightforward method for improving
their outcomes, and Public Health England have supported this
by publishing mouth care guidance for patients with COVID-
19 (31).
This is the first study to quantify the effect of periodontal
disease on risk of COVID-19 infection and related outcomes. As
such, there are several strengths to our study. First of all, this
is the largest study to date to quantify the association between
periodontal disease and COVID-19. Secondly, the utilization of
UK Biobank, a national resource with high quality measures
linked to COVID-19 test results enabled our quantitative analysis
of association between periodontal disease and COVID-19
outcomes. Finally, our study demonstrates robust results using
both imputed and complete cases.
Our study also has some limitations. Delayed information
of hospital admission and mortality (updated until June 2020)
limited the number of study cases, and has been recognized
as an avenue for further investigation. The use of self-
reported oral health indicators as a surrogate for signs of
periodontal disease could introduce bias, as research suggests
self-reported periodontal disease prevalence is underestimated
in populations (32, 33). We are also aware that loose teeth,
and painful or bleeding gums could result from trauma or
endodontic diseases, however, there is evidence that the validity
of a periodontal disease diagnosis is not compromised when
self-reported responses of bleeding gums and loose teeth are
utilized (18). In addition, the dataset held no information
regarding any periodontal treatment that the participants had
received in the time between reporting the oral measures
and receiving the results of the COVID-19 test. Given that
periodontal therapy can reverse or prevent disease activity,
participantsmay have experienced changes to periodontal disease
status between self-report at UK Biobank assessment center and
undertaking a COVID-19 test. Furthermore, the oral measures
(painful gum, bleeding gum and loose teeth) in this study
may be due to oral dysbiosis but this causal association was
not measurable within the UK Biobank dataset. Lastly, as the
pandemic continues to take hold, the study follow up time for
hospital admission and mortality was relatively short (until May
and June 2020); the numbers of COVID-19 positive cases may
have been underreported during the early stages of the pandemic.
Suggestions for future research include: (1) Using updated
information of additional COVID-19 test results with longer
follow up in order to acquire more precise estimates of the
effect of periodontal disease on risk of COVID-19 infection and
associated outcomes. (2) Utilization of linked dental and hospital
records in future analyses. This could provide more accurate
and recent information on oral health status in comparison to
the self-reported periodontal disease responses at UK Biobank
assessment centers and account for any change in oral health
status following dental treatment.
CONCLUSIONS
Our study demonstrated an increased risk of mortality following
COVID-19 infection in people with periodontal disease. The
findings suggest that while periodontal diseasemight not increase
risk of COVID-19 infection directly, it may be associated with
COVID-19 pathology and increase the risk of death. This
indicates the importance of good oral hygiene and periodontal
disease management, particularly while dental services are
working below their pre-COVID-19 capacity levels.
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